These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30770055)

  • 1. Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine.
    Oh TK; Oh AY; Ryu JH; Koo BW; Song IA; Nam SW; Jee HJ
    Br J Anaesth; 2019 Mar; 122(3):370-378. PubMed ID: 30770055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study.
    Min BH; Oh TK; Song IA; Jeon YT
    BMC Anesthesiol; 2020 Jul; 20(1):178. PubMed ID: 32693776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study.
    Kim NY; Koh JC; Lee KY; Kim SS; Hong JH; Nam HJ; Bai SJ
    J Clin Anesth; 2019 Nov; 57():97-102. PubMed ID: 30939422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery.
    Oh TK; Ryu JH; Nam S; Oh AY
    BMC Anesthesiol; 2020 Feb; 20(1):41. PubMed ID: 32079528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex.
    Oh TK; Ji E; Na HS
    Medicine (Baltimore); 2019 Jun; 98(26):e16142. PubMed ID: 31261539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
    Azimaraghi O; Ahrens E; Wongtangman K; Witt AS; Rupp S; Suleiman A; Tartler TM; Wachtendorf LJ; Fassbender P; Choice C; Houle TT; Eikermann M; Schaefer MS
    Br J Anaesth; 2023 Mar; 130(3):296-304. PubMed ID: 36535827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuromuscular block reversal with sugammadex versus neostigmine on postoperative respiratory outcomes after major abdominal surgery: a randomized-controlled trial.
    Alday E; Muñoz M; Planas A; Mata E; Alvarez C
    Can J Anaesth; 2019 Nov; 66(11):1328-1337. PubMed ID: 31165457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
    Suleiman A; Munoz-Acuna R; Azimaraghi O; Houle TT; Chen G; Rupp S; Witt AS; Azizi BA; Ahrens E; Shay D; Wongtangman K; Wachtendorf LJ; Tartler TM; Eikermann M; Schaefer MS
    Anaesthesia; 2023 Mar; 78(3):294-302. PubMed ID: 36562202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design.
    Krause M; McWilliams SK; Bullard KJ; Mayes LM; Jameson LC; Mikulich-Gilbertson SK; Fernandez-Bustamante A; Bartels K
    Anesth Analg; 2020 Jul; 131(1):141-151. PubMed ID: 31702700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery.
    Boon M; Martini C; Yang HK; Sen SS; Bevers R; Warlé M; Aarts L; Niesters M; Dahan A
    PLoS One; 2018; 13(5):e0197036. PubMed ID: 29791482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.